20-quarter listed-company comparison

Hospitals/Medical Services Stocks in India

Hospitals/Medical Services: Park Medi World Ltd owns the largest revenue base; Gaudium IVF and Women Health Ltd has the fastest current growth.

The 3 Hospitals/Medical Services companies listed in India are Park Medi World Ltd (₹12.0K Cr, the largest), Unihealth Hospitals Ltd and Gaudium IVF and Women Health Ltd. 1 of 1 covered company beats NIFTY 500 on relative strength. Readings are as of 28 Sep 2026.

01 · the index people search for

Nifty Hospitals/Medical Services Index — Constituents & Performance

All 3 listed Indian Hospitals/Medical Services companies are named here, largest first — the same constituent set people search for as the Nifty Hospitals/Medical Services index. Every figure is equal-weighted across those companies and carries its own as-of date. One large constituent cannot set the reading.

02 · the sector itself · before any single company

How has Hospitals/Medical Services moved against NIFTY 500?

The line below covers up to 3 years and opens on the 3Y view; the buttons cut it shorter. Over the most recent two of them this sector is 186% ahead of NIFTY 500. Earnings across its companies fell 46% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 64 weeks running.

LEADER · ahead 64w·Price up, without the fundamentals confirming6 of 7 companies ahead of NIFTY 500 by 5% or more over three months

RS ↑64w · 7/7 >200d (+1) · 6/7 lead (+3) · EPS —

Hospitals/Medical Services, equal-weighted, based at 200 NIFTY 500, same base, same start trailing 12-month earnings per share rising falling

Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 7 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.

03 · sector relative strength, before individual stocks

Is Hospitals/Medical Services outperforming NIFTY 500?

Hospitals/Medical Services has outperformed NIFTY 500 by 301.3% over the last 52 weeks. Over 13 weeks the gap is a lead of 10.8%. 1 of 1 covered company currently beats NIFTY on Mansfield relative strength, so leadership inside the sector is broad. Unihealth Hospitals Ltd is the strongest against the sector itself at +5.2%.

+10.8%Sector vs NIFTY 500 · 13 weeks

+301.3%Sector vs NIFTY 500 · 52 weeks

1/1Stocks leading NIFTY 500

1/1Stocks leading sector

Sector metric: — as of latest available · unclassified · direction unavailable.

The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.

Bottom line

Hospitals/Medical Services has outperformed NIFTY 500 by 301.3% over 52 weeks and 10.8% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself. Park Medi World Ltd leads with revenue of ₹1,756 crore, based on 2 of 3 comparable companies through Jun 2026.

Companies

complete canonical membership

Combined market value

₹13.9K Cr

Park Medi World Ltd

Revenue growing

1/1

positive TTM year-on-year growth

Beating NIFTY 500

1/1

positive Mansfield relative strength

Comparing 2 of 3

04 · research priority, made explicit

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%

Unihealth Hospitals Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 52.8% evidence confidence.

How this score is built, and what the marks mean

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

Company	Score	Price stage	Growth & earnings/35	Capital efficiency/25	Valuation/20	Relative strength/20
1Unihealth Hospitals LtdUNIHEALTH	68.4/100Thin evidence · provisional53% evidence	LEADER	18.7/35 Revenue — · PAT — · OPM change -4 pp 26% evidence	22.5/25 ROCE 24.5% · OPM 34% 95% evidence	10.0/20 P/E 39.6× · PEG — 0% evidence	17.2/20 RS sector 5.2% · RS bench 50.2% · 1Y 271.2%12 of 12 weeks ahead 100% evidence
Exact sum: 18.7 + 22.5 + 10 + 17.2 = 68.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2Gaudium IVF and Women Health LtdGAUDIUMIVF	49.9/100Thin evidence · provisional57% evidence	BREAKING OUT	12.2/35 Revenue 16.3% · PAT 10.6% · OPM change -16.5 pp 95% evidence	17.7/25 ROCE 29.3% · OPM 12.5% 95% evidence	10.0/20 P/E 36.2× · PEG — 0% evidence	10.0/20 RS sector — · RS bench — · 1Y —10 of 12 weeks ahead 0% evidence
Exact sum: 12.2 + 17.7 + 10 + 10 = 49.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3Park Medi World LtdPARKHOSPS	56.6/100Thin evidence · provisional35% evidence	TURNING	16.6/35 Revenue — · PAT — · OPM change 0 pp 45% evidence	20.0/25 ROCE 19.5% · OPM 26% 76% evidence	10.0/20 P/E 43.4× · PEG — 0% evidence	10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence
Exact sum: 16.6 + 20 + 10 + 10 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

05 · what price has already done

Market action

Unihealth Hospitals Ltd has the strongest one-year price move in Hospitals/Medical Services at +271.2%. It also leads on Mansfield relative strength against NIFTY at +50.2%. 1 of 1 covered company is above zero on that measure. Every line covers 313 weekly closes through 2026-09-25.

Price and relative strength

Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

06 · the story behind the numbers

Hospitals/Medical Services — the story behind the numbers

This is the written read behind the Hospitals/Medical Services figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 28 Jul 2026. 3 themes are live here.

The verdict is Cautious. While growth metrics are high, regulatory penalties and lack of guidance introduce uncertainty. The operating leverage inflection depends on occupancy improving to 70%+.

The Hospitals/Medical Services sector analysis for the week ending 2026-07-19 centers on Gujarat Kidney & Super Speciality Ltd (GKSL). The constituent reported Q4 FY26 total income of ₹31.29 crore, marking a 218.3% YoY increase from ₹9.83 crore in Q4FY25. Profit after tax surged 259.7% YoY to ₹4.82 crore.

How old this read is: This read comes from our Hospitals/Medical Services sector brief dated 28 Jul 2026 — 62 days old. The numbers above it are newer than the words here.

What is live in this sector right now

Live theme	Severity	Evidence on file
Company paid ₹6,60,800 penalty to NSE and BSE for failing to submit quarterly financial results within prescribed timelines under Regulation 33 of SEBI LODR 2015, with additional…Named for GKSL	medium	“Company paid ₹6,60,800 penalty to NSE and BSE for failing to submit quarterly financial results within prescribed timelines under Regulation 33 of SEBI LODR 2015, with additional ₹20,000 fine for board meeting…” Company stated no additional financial impact expected from regulatory action and penalty settlement closes the matter with both exchanges.
Company faces heavy reliance on key doctors creating attrition risk, with revenue concentrated in IPD (73%) and Gujarat region limiting diversification.Named for GKSL	medium	“Company faces heavy reliance on key doctors creating attrition risk, with revenue concentrated in IPD (73%) and Gujarat region limiting diversification.”
Multiple regulatory violations cited including delay in furnishing prior intimation about Board of Directors meeting, contravening listing requirements.Named for GKSL	low	“Multiple regulatory violations cited including delay in furnishing prior intimation about Board of Directors meeting, contravening listing requirements.” Company stated levy of fines has no impact on financial, operational, or any other activities.

Sources: our Hospitals/Medical Services sector brief, 28 Jul 2026 · company earnings-call transcripts.

07 · compare level, then change

Revenue Scale & Growth Durability

Park Medi World Ltd has the highest Revenue among the 3 Hospitals/Medical Services companies compared here, at ₹1,756 crore. Gaudium IVF and Women Health Ltd is next at ₹106 crore. Gaudium IVF and Women Health Ltd has the highest Revenue growth at 16.3%, so level and change sit with different companies.

What the numbers say: Park Medi World Ltd is the scale leader at ₹1,756 crore, 16.6× the revenue of Gaudium IVF and Women Health Ltd. Gaudium IVF and Women Health Ltd's growth is 16.3% from a ₹106 crore base, with 8 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

LeaderPark Medi World Ltd · ₹1,756 crore

Gap16.6× versus #2 · Gaudium IVF and Women Health Ltd

Persistence3/3 recent comparable periods

Coverage2/3 companies · 21 observations

Investor read: Park Medi World Ltd is the scale benchmark; Gaudium IVF and Women Health Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Park Medi World Ltd's growth falls below Gaudium IVF and Women Health Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.

Revenuelargest

1Park Medi World Ltd PARKHOSPS₹1.8K Cr

2Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified₹106 Cr

Revenue growthfastest growers

1Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified16%

Revenue · company comparison

2/3 level · 1/3 change

On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

Company	Revenue	Revenue growth	Reported
Park Medi World Ltd PARKHOSPS	₹476 Cr	19%	Jun 2026
Unihealth Hospitals Ltd UNIHEALTH⚠ unverified	₹65 Cr	16%	Mar 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified	₹19 Cr	9.1%	Jun 2026

Full 15-quarter history · every available company

Revenue · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024₹32 Cr

Dec 2024₹14 Cr

Mar 2025₹27 Cr

Jun 2025₹18 Cr

Sep 2025₹32 Cr

Dec 2025₹25 Cr

Mar 2026₹30 Cr

Jun 2026₹19 Cr

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024₹348 Cr

Mar 2025₹354 Cr

Jun 2025₹399 Cr

Sep 2025₹410 Cr

Dec 2025₹410 Cr

Mar 2026₹460 Cr

Jun 2026₹476 Cr

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023₹22 Cr

Mar 2024₹27 Cr

Jun 2024—

Sep 2024₹43 Cr

Dec 2024—

Mar 2025₹56 Cr

Jun 2025—

Sep 2025₹67 Cr

Dec 2025—

Mar 2026₹65 Cr

Jun 2026—

Revenue growth · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025-0.8%

Dec 202570%

Mar 202613%

Jun 20269.1%

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 202518%

Mar 202630%

Jun 202619%

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 202495%

Dec 2024—

Mar 2025107%

Jun 2025—

Sep 202556%

Dec 2025—

Mar 202616%

Jun 2026—

08 · compare level, then change

Operating Economics & Margin Trend

Unihealth Hospitals Ltd has the highest OPM among the 3 Hospitals/Medical Services companies compared here, at 34%. Park Medi World Ltd is next at 26%. Park Medi World Ltd has the highest Margin change at 0 percentage points, so level and change sit with different companies. 3 of 3 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Unihealth Hospitals Ltd leads opm at 34%; Park Medi World Ltd leads margin change at 0 percentage points.

LeaderUnihealth Hospitals Ltd · 34%

Gap30.8% versus #2 · Park Medi World Ltd

Persistence2/4 recent comparable periods

Coverage3/3 companies · 22 observations

Investor read: Unihealth Hospitals Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.

OPMhighest

1Unihealth Hospitals Ltd UNIHEALTH⚠ unverified34%

2Park Medi World Ltd PARKHOSPS26%

3Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified13%

Margin changefastest expanders

1Park Medi World Ltd PARKHOSPS0.0 pp

2Unihealth Hospitals Ltd UNIHEALTH⚠ unverified−4.0 pp

3Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified−16.5 pp

Operating margin · company comparison

3/3 level · 3/3 change

All-company data · latest reported quarter

Company	OPM	Margin change	Reported
Unihealth Hospitals Ltd UNIHEALTH⚠ unverified	34%	−4.0 pp	Mar 2026
Park Medi World Ltd PARKHOSPS	26%	0.0 pp	Jun 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified	13%	−16.5 pp	Jun 2026

Full 15-quarter history · every available company

OPM · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 202440%

Dec 202439%

Mar 202532%

Jun 202529%

Sep 202543%

Dec 202527%

Mar 202640%

Jun 202613%

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 202427%

Dec 202424%

Mar 202525%

Jun 202526%

Sep 202527%

Dec 202524%

Mar 202628%

Jun 202626%

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 202332%

Mar 202439%

Jun 2024—

Sep 202435%

Dec 2024—

Mar 202538%

Jun 2025—

Sep 202548%

Dec 2025—

Mar 202634%

Jun 2026—

Margin change · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025+3.4 pp

Dec 2025−12.5 pp

Mar 2026+7.7 pp

Jun 2026−16.5 pp

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025−0.4 pp

Dec 20250.0 pp

Mar 2026+3.0 pp

Jun 20260.0 pp

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024+3.0 pp

Dec 2024—

Mar 2025−1.0 pp

Jun 2025—

Sep 2025+13.0 pp

Dec 2025—

Mar 2026−4.0 pp

Jun 2026—

09 · compare level, then change

Profit Scale & Acceleration

Park Medi World Ltd has the highest Net profit among the 3 Hospitals/Medical Services companies compared here, at ₹298 crore. Gaudium IVF and Women Health Ltd is next at ₹23 crore. Gaudium IVF and Women Health Ltd has the highest Profit growth at 10.6%, so level and change sit with different companies.

What the numbers say: Park Medi World Ltd leads with ₹298 crore of TTM profit, 12.9× the profit of Gaudium IVF and Women Health Ltd. Gaudium IVF and Women Health Ltd shows 10.6% growth from a ₹23 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

LeaderPark Medi World Ltd · ₹298 crore

Gap12.9× versus #2 · Gaudium IVF and Women Health Ltd

Persistence3/3 recent comparable periods

Coverage2/3 companies · 21 observations

Investor read: Park Medi World Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.

Net profitlargest

1Park Medi World Ltd PARKHOSPS₹298 Cr

2Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified₹23 Cr

Profit growthfastest growers

1Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified11%

Net profit · company comparison

2/3 level · 1/3 change

All-company data · latest reported quarter

Company	Net profit	Profit growth	Reported
Park Medi World Ltd PARKHOSPS	₹89 Cr	35%	Jun 2026
Unihealth Hospitals Ltd UNIHEALTH⚠ unverified	₹17 Cr	-5.6%	Mar 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified	₹2 Cr	-42%	Jun 2026

Full 15-quarter history · every available company

Net profit · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024₹8 Cr

Dec 2024₹3 Cr

Mar 2025₹6 Cr

Jun 2025₹3 Cr

Sep 2025₹9 Cr

Dec 2025₹4 Cr

Mar 2026₹8 Cr

Jun 2026₹2 Cr

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024₹46 Cr

Mar 2025₹52 Cr

Jun 2025₹66 Cr

Sep 2025₹79 Cr

Dec 2025₹53 Cr

Mar 2026₹77 Cr

Jun 2026₹89 Cr

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023₹4 Cr

Mar 2024₹6 Cr

Jun 2024—

Sep 2024₹9 Cr

Dec 2024—

Mar 2025₹18 Cr

Jun 2025—

Sep 2025₹29 Cr

Dec 2025—

Mar 2026₹17 Cr

Jun 2026—

Profit growth · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 202517%

Dec 20256.8%

Mar 202629%

Jun 2026-42%

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 202515%

Mar 202648%

Jun 202635%

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024125%

Dec 2024—

Mar 2025200%

Jun 2025—

Sep 2025222%

Dec 2025—

Mar 2026-5.6%

Jun 2026—

10 · compare level, then change

Return On Capital Employed

Gaudium IVF and Women Health Ltd has the highest ROCE among the 3 Hospitals/Medical Services companies compared here, at 29.3%. Unihealth Hospitals Ltd is next at 24.5%. Unihealth Hospitals Ltd has the highest ROCE change at +5.3 percentage points, so level and change sit with different companies. 3 of 3 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Gaudium IVF and Women Health Ltd leads ROCE at 29.3%, 4.8 percentage points above Unihealth Hospitals Ltd. Unihealth Hospitals Ltd has the strongest latest improvement at +5.3 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

LeaderGaudium IVF and Women Health Ltd · 29.3%

Gap19.6% versus #2 · Unihealth Hospitals Ltd

Persistence0/1 recent comparable periods

Coverage3/3 companies · 11 observations

Investor read: Gaudium IVF and Women Health Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.

ROCEhighest

1Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified29%

2Unihealth Hospitals Ltd UNIHEALTH⚠ unverified25%

3Park Medi World Ltd PARKHOSPS20%

ROCE changefastest improvers

1Unihealth Hospitals Ltd UNIHEALTH⚠ unverified+5.3 pp

2Park Medi World Ltd PARKHOSPS−1.0 pp

3Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified−29.2 pp

Return on capital · company comparison

3/3 level · 3/3 change

Withheld from this chart: Park Medi World Ltd (PARKHOSPS) — its two data sources disagree by up to 16% on reported income across 6 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

All-company data · latest reported quarter

Company	ROCE	ROCE change	Reported
Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified	20%	−29.2 pp	Jun 2026
Unihealth Hospitals Ltd UNIHEALTH⚠ unverified	19%	+5.3 pp	Mar 2026

Full 15-quarter history · every available company

ROCE · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 202413%

Sep 202425%

Dec 2024—

Mar 202549%

Jun 2025—

Sep 2025—

Dec 202568%

Mar 202620%

Jun 2026—

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 20235.5%

Mar 202416%

Jun 2024—

Sep 202416%

Dec 2024—

Mar 202514%

Jun 2025—

Sep 202519%

Dec 2025—

Mar 202619%

Jun 2026—

ROCE change · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 2025—

Mar 2026−29.2 pp

Jun 2026—

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025−1.4 pp

Jun 2025—

Sep 2025+2.7 pp

Dec 2025—

Mar 2026+5.3 pp

Jun 2026—

11 · compare level, then change

Valuation Against Growth & Quality

No company in this Hospitals/Medical Services comparison reports a valuation figure this section can compare, so the PEG rank is empty. On P/E, Gaudium IVF and Women Health Ltd is lowest at 36.2×, across 3 of 3 companies with a usable reading.

What the numbers say: There is not enough comparable evidence to name a reliable peg leader.

LeaderNo comparable leader

GapNot enough peers

PersistenceNot enough history

Coverage0/3 companies · 0 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.

PEGlowest PEG

—Not enough comparable data—

P/Elowest P/E

1Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified36.2

2Unihealth Hospitals Ltd UNIHEALTH⚠ unverified39.6

3Park Medi World Ltd PARKHOSPS43.4

Valuation · company comparison

0/3 level · 3/3 change

All-company data · latest reported quarter

Company	PEG	P/E	Reported
Park Medi World Ltd PARKHOSPS	—	48.0	Jun 2026
Unihealth Hospitals Ltd UNIHEALTH⚠ unverified	—	21.6	Mar 2026
Gaudium IVF and Women Health Ltd GAUDIUMIVF⚠ unverified	—	36.2	Jun 2026

Full 15-quarter history · every available company

No consistent historical series is available for peg.

P/E · reported quarter history

Gaudium IVF and Women Health Ltd · GAUDIUMIVF⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 2025—

Mar 202622.9

Jun 202636.2

Park Medi World Ltd · PARKHOSPS

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 202527.8

Mar 202633.0

Jun 202648.0

Unihealth Hospitals Ltd · UNIHEALTH⚠ unverified

Mar 2020—

Mar 2021—

Mar 2022—

Mar 2023—

Sep 202346.5

Mar 202420.2

Jun 2024—

Sep 202422.0

Dec 2024—

Mar 202514.2

Jun 2025—

Sep 20259.9

Dec 2025—

Mar 202621.6

Jun 2026—

12 · before the conclusion, check the blind spots

What can make this comparison misleading?

This Hospitals/Medical Services comparison names 7 specific ways its own evidence can mislead, all listed below. All 3 companies here report on comparable dates, so no rank carries a stale marker. 2 draw at least one figure from a second feed with too little overlap to cross-check. 1 has second-feed figures withheld because the two sources disagree.

Keep these limits visible

A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
2 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
1 company is missing from the second-feed metrics by decision, not by absence: the two sources disagree, so nothing from the second is drawn. Read those rows as narrower evidence, never as a weaker business.
Thin comparisons: Revenue, Net profit, Valuation have fewer than three usable current readings.

13 · evidence and freshness

How was this comparison built?

This comparison is built from the reported filings of 3 Hospitals/Medical Services companies, normalized to a common ₹ scale and a shared quarter axis of up to 15 quarters each. Fundamentals run through Jun 2026 and market data through 2026-09-25. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

FundamentalsThrough Jun 2026 · up to 15 quarters per company

Market dataThrough 2026-09-25 · weekly price and relative-strength history

Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.

Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.

Source standing0 cross-checked · 2 unverified · 1 withheld, of 3 graded companies.

How a second data feed is admitted, and what happens when it disagrees

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.

14 · questions investors ask, short speakable answers

Hospitals/Medical Services company comparison FAQs

These 21 answers restate the Hospitals/Medical Services comparison above in question form. Every one is computed from the same 3 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-09-25. Nothing here is estimated, and none of it is a recommendation.

Is the Hospitals/Medical Services sector outperforming NIFTY 500?

Which Hospitals/Medical Services company is largest by revenue?

Park Medi World Ltd leads with revenue of ₹1,756 crore, based on 2 of 3 comparable companies through Jun 2026.

Which Hospitals/Medical Services company is growing fastest?

Gaudium IVF and Women Health Ltd has the fastest current revenue growth at 16.3%, across 1 of 3 comparable companies.

Which Hospitals/Medical Services company has the strongest 4-Factor Sector Score?

Unihealth Hospitals Ltd ranks first at 68.4/100 with 52.8% evidence confidence. The score prioritizes research; it is not a buy recommendation.

How much history does this Hospitals/Medical Services comparison include?

The page compares up to 15 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

Is there a Nifty Hospitals/Medical Services index?

NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers Hospitals/Medical Services, this page builds its own equal-weight basket of 3 listed Hospitals/Medical Services companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.

Which are the best Hospitals/Medical Services stocks in India?

Ranked by this page's four-factor score, Unihealth Hospitals Ltd places first among 3 listed Hospitals/Medical Services companies, followed by Gaudium IVF and Women Health Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

How many Hospitals/Medical Services stocks are listed in India?

This comparison covers 3 listed Hospitals/Medical Services companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

Which Hospitals/Medical Services company is the biggest?

Park Medi World Ltd is the largest, with trailing-twelve-month revenue of ₹1,756 crore, ahead of Gaudium IVF and Women Health Ltd at ₹106 crore. That covers 2 of 3 companies with comparable reporting through Jun 2026.

Which Hospitals/Medical Services company has the best profit margins?

Unihealth Hospitals Ltd has the highest operating margin at 34%, from 3 of 3 comparable companies. Park Medi World Ltd shows the biggest recent improvement, at 0 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

Which Hospitals/Medical Services company makes the most profit?

Park Medi World Ltd earns the most, at ₹298 crore of trailing-twelve-month net profit, from 2 of 3 comparable companies. Gaudium IVF and Women Health Ltd has the fastest profit growth at 10.6%, though growth off a small or recovering profit base overstates how much has actually changed.

Which Hospitals/Medical Services company earns the highest return on capital?

Gaudium IVF and Women Health Ltd leads on return on capital employed at 29.3%, across 3 of 3 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

Is the Hospitals/Medical Services sector beating the market?

Hospitals/Medical Services has outperformed NIFTY 500 by 301.3% over the last 52 weeks and 10.8% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 1 of 1 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

Which Hospitals/Medical Services stock has the strongest price momentum?

Unihealth Hospitals Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

Which Hospitals/Medical Services company scores highest for research priority?

Unihealth Hospitals Ltd scores 68.4 out of 100 with 52.8% evidence confidence, from 18.7 points on growth and earnings, 22.5 on capital efficiency, 10 on valuation and 17.2 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

How many Hospitals/Medical Services companies does this comparison cover, and over what period?

It compares 3 listed companies over up to 15 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

What is the total market cap of the Hospitals/Medical Services sector?

The 3 Hospitals/Medical Services companies on this page carry ₹13,889 crore of combined market value. Park Medi World Ltd is the largest at ₹12,034 crore, about 87% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-09-28.

How is the Hospitals/Medical Services sector performing?

1 of the 1 covered Hospitals/Medical Services companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 301.3% ahead of NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-09-28.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.

About

Not SEBI Registered !! Not Investment advice !!